AtheroMed Inc. has raised $4.5 million, according to a regulatory filing with the U.S. Securities and Exchange Commission on Wednesday.
The Menlo Park-based company sold equity, options, warrants and securities to raise the funds. The company is developing treatments for peripheral arterial disease.
No comments:
Post a Comment